Case number 2017-2557
Tris Pharma, Inc. v. Actavis Laboratories FL, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | TRIS PHARMA, INC. v. ACTAVIS LABORATORIES FL, INC. [OPINION WITHDRAWN - NONPRECEDENTIAL] [nonprecedential] (0) |
| Apr 23, 2021 | 0 | TRIS PHARMA, INC. v. ACTAVIS LABORATORIES FL, INC. [REVISED OPINION- NONPRECEDENTIAL] [nonprecedential] (0) |
| Feb 22, 2019 | 68 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [587903] [17-2557, 17-2559, 17-2560] [PBC] [Entered: 02/22/2019 10:36 AM] (1) |
| Feb 12, 2019 | 67 | **TEXT ONLY** ORDER granting motion to withdraw attorney Cynthia Lambert Hardman [66] filed by Appellee Actavis Laboratories FL, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [585051] [JAB] [Entered: 02/12/2019 08:01 AM] (0) |
| Feb 11, 2019 | 66 | MOTION of Appellee Actavis Laboratories FL, Inc. to withdraw counsel Cynthia L. Hardman [Consent: unopposed]. Service: 02/11/2019 by email. [585007] [17-2557] [Michael Cottler] [Entered: 02/11/2019 05:58 PM] (4) |
| Jan 16, 2019 | 65 | JUDGMENT filed. VACATED AND REMANDED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [578483] [17-2557, 17-2559, 17-2560] [PBC] [Entered: 01/16/2019 11:09 AM] (2) |
| Jan 16, 2019 | 64 | OPINION filed for the court by Newman, Circuit Judge; O'Malley, Circuit Judge and Chen, Circuit Judge. Nonprecedential Opinion. [578476] [17-2557, 17-2559, 17-2560] [PBC] [Entered: 01/16/2019 11:05 AM] (20) |
| Jan 16, 2019 | 63 | ORDER filed. The petition [61] is granted to the limited extent noted in the order. The court shall withdraw the opinion and judgment issued November 20, 2018, and issue a modified version of the opinion incorporating the amendments described in the order. A new judgment shall issue as of the date of issuance of the modified opinion. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [578468] [17-2557, 17-2559, 17-2560] [PBC] [Entered: 01/16/2019 10:50 AM] (2) |
| Dec 20, 2018 | 62 | 3 paper copies of the petition for panel rehearing [61] received from Appellee Actavis Laboratories FL, Inc. [573606] [JAB] [Entered: 12/20/2018 03:00 PM] (0) |
| Dec 20, 2018 | 61 | Petition for panel rehearing filed by Appellee Actavis Laboratories FL, Inc.. Service: 12/20/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 12/26/2018 [573525] [17-2557] [William Jay] [Entered: 12/20/2018 01:07 PM] (29) |
| Nov 20, 2018 | 60 | JUDGMENT filed. VACATED AND REMANDED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [566573] [17-2557, 17-2559, 17-2560] Vacated pursuant to court's order. See Doc. No. [63].--[Edited 01/16/2019 by JAB to vacate judgment per court order] [PBC] [Entered: 11/20/2018 09:25 AM] (2) |
| Nov 20, 2018 | 59 | OPINION filed for the court by Newman, Circuit Judge; O'Malley, Circuit Judge and Chen, Circuit Judge. Nonprecedential Opinion. [566572] [17-2557, 17-2559, 17-2560] Withdrawn and modified pursuant to the Court's order. See Doc No. [63]. [PBC] [Entered: 11/20/2018 09:24 AM] (20) |
| Sep 6, 2018 | 58 | Submitted after ORAL ARGUMENT by Mr. Errol Taylor for Tris Pharma, Inc. and Mr. William M. Jay for Actavis Laboratories FL, Inc.. Panel: Judge: Newman , Judge: O'Malley , Judge: Chen. [547626] [JCP] [Entered: 09/06/2018 11:34 AM] (0) |
| Aug 15, 2018 | 57 | Response to oral argument order from the Appellee Actavis Laboratories FL, Inc.. Designating William M. Jay to argue.. Designating 15 minutes for argument. [17-2557] [William Jay] [Entered: 08/15/2018 05:07 PM] (0) |
| Aug 15, 2018 | 56 | Response to oral argument order from the Appellant Tris Pharma, Inc.. Designating Errol B. Taylor to argue.. Designating 10 minutes for argument. Reserving 5 minutes for rebuttal. [17-2557] [Anna Brook] [Entered: 08/15/2018 04:19 PM] (0) |
| Jul 20, 2018 | 55 | NOTICE OF CALENDARING. Panel: 1809G. Case scheduled Sep 06, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to oral argument order due: 08/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [537306] [JAB] [Entered: 07/20/2018 12:29 PM] (0) |
| Jun 29, 2018 | 54 | Notice from Appellee Actavis Laboratories FL, Inc. regarding conflicts with oral argument (September 4, October 1-3). Service: 06/29/2018 by email. [532843] [17-2557] [William Jay] [Entered: 06/29/2018 01:18 PM] (2) |
| Apr 9, 2018 | 53 | 6 paper copies of the Opening Response Brief [32] received from Appellee Actavis Laboratories FL, Inc. [511776] [SJL] [Entered: 04/09/2018 03:42 PM] (0) |
| Apr 4, 2018 | 52 | Notice to counsel for Appellee Actavis Laboratories FL, Inc.: The record of this case indicates that the paper copies of the response brief (see Fed. Cir. R. 30(a)(5) and Fed. Cir. R. 31(b)) have not been filed. The paper copies of the brief should be received by the court on or before 04/18/2018. Service as of this date by the Clerk of Court. [510681] [SJ] [Entered: 04/04/2018 03:56 PM] (0) |
| Apr 2, 2018 | 51 | 6 paper copies of the Confidential Joint Appendix [44] received from Appellant Tris Pharma, Inc. [509829] [SJL] [Entered: 04/02/2018 01:33 PM] (0) |
| Mar 29, 2018 | 48 | Notice from Appellee Actavis Laboratories FL, Inc. regarding conflicts with oral argument (June 5, June 7-8, July 10, July 13, and August 9). Service: 03/29/2018 by email. [509357] [17-2557] [William Jay] [Entered: 03/29/2018 05:23 PM] (2) |
| Mar 29, 2018 | 47 | Notice from Appellant Tris Pharma, Inc. regarding conflicts with oral argument (June 8, 2018). Service: 03/29/2018 by email. [509347] [17-2557] [Anna Brook] [Entered: 03/29/2018 05:00 PM] (2) |
| Mar 27, 2018 | 46 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category.. [508319] [SJ] [Entered: 03/27/2018 02:47 PM] (0) |
| Mar 23, 2018 | 50 | 6 CDs of the Corresponding Briefs (Confidential) [44], [36], [26] received from Appellant Tris Pharma, Inc. [509568] [JCP] [Entered: 03/30/2018 01:09 PM] (0) |
| Mar 23, 2018 | 49 | 6 CDs of the Corresponding Briefs (Non-Confidential) [45], [36], [26] received from Appellant Tris Pharma, Inc. [509566] [JCP] [Entered: 03/30/2018 01:08 PM] (0) |
| Mar 22, 2018 | 45 | APPENDIX FILED for Tris Pharma, Inc. [39]. Number of Pages: 604. Service: 03/22/2018 by email. [508318] [SJ] [Entered: 03/27/2018 02:47 PM] (604) |
| Mar 22, 2018 | 44 | CONFIDENTIAL JOINT APPENDIX FILED for Tris Pharma, Inc. [40]. Number of Pages: 604. Service: 03/22/2018 by email. The paper copies of the brief should be received by the court on or before 04/03/2018. [508317] [SJ] [Entered: 03/27/2018 02:44 PM] (0) |
| Mar 22, 2018 | 43 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Actavis Laboratories FL, Inc.. Service: 03/22/2018 by email. [507382] [17-2557] [William Jay] [Entered: 03/22/2018 06:52 PM] (4) |
| Mar 22, 2018 | 42 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Tris Pharma, Inc.. Service: 03/22/2018 by email. [507367] [17-2557] [Anna Brook] [Entered: 03/22/2018 05:42 PM] (5) |
| Mar 22, 2018 | 41 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Tris Pharma, Inc. and Appellee Actavis Laboratories FL, Inc.. Service: 03/22/2018 by email. [507364] [17-2557] [Anna Brook] [Entered: 03/22/2018 05:37 PM] (4) |
| Mar 22, 2018 | 40 | TENDERED from Appellee Actavis Laboratories FL, Inc. and Appellant Tris Pharma, Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 03/22/2018 by email. [507243] [17-2557] [Anna Brook] [Entered: 03/22/2018 03:48 PM] (0) |
| Mar 22, 2018 | 39 | TENDERED from Appellee Actavis Laboratories FL, Inc. and Appellant Tris Pharma, Inc.. Title: JOINT APPENDIX. Service: 03/22/2018 by email. [507241] [17-2557] [Anna Brook] [Entered: 03/22/2018 03:47 PM] (604) |
| Mar 22, 2018 | 38 | Notice of intent to file corresponding briefs on CD-ROM for Appellant Tris Pharma, Inc.. Service: 03/22/2018 by email. [507239] [17-2557] [Anna Brook] [Entered: 03/22/2018 03:44 PM] (3) |
| Mar 22, 2018 | 37 | 6 paper copies of the Reply Brief [36] received from Appellant Tris Pharma, Inc. [507194] [SJL] [Entered: 03/22/2018 02:38 PM] (0) |
| Mar 15, 2018 | 35 | TENDERED from Appellant Tris Pharma, Inc.. Title: REPLY BRIEF. Service: 03/15/2018 by email. [505542] [Anna Brook] [Entered: 03/15/2018 01:42 PM] (36) |
| Mar 15, 2018 | 36 | REPLY BRIEF FILED for Appellant Tris Pharma, Inc. [35]. Number of Pages: 30. Service: 03/15/2018 by email. The paper copies of the brief should be received by the court on or before 03/26/2018. Appendix is due 03/22/2018. [506287] [SJ] [Entered: 03/19/2018 03:46 PM] (36) |
| Feb 22, 2018 | 34 | **TEXT ONLY** ORDER granting motion to extend time to file reply brief [33] filed by Appellant Tris Pharma, Inc. The reply brief is due 03/15/2018. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [500228] [MJL] [Entered: 02/22/2018 11:07 AM] (0) |
| Feb 22, 2018 | 33 | MOTION of Appellant Tris Pharma, Inc. to extend the time to 03/15/2018 to file the reply brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/22/2018 by email. [500215] [Jordan Markham] [Entered: 02/22/2018 10:56 AM] (6) |
| Feb 15, 2018 | 32 | BRIEF FILED for Appellee Actavis Laboratories FL, Inc. [31]. Number of Pages: 60. Service: 02/15/2018 by email. The paper copies of the brief should be received by the court on or before 02/26/2018. Appellant Tris Pharma, Inc. reply brief is due 03/01/2018. [498830] [SJ] [Entered: 02/16/2018 11:13 AM] (71) |
| Feb 15, 2018 | 31 | TENDERED from Appellee Actavis Laboratories FL, Inc.. Title: RESPONSE BRIEF. Service: 02/15/2018 by email. [498341] [William Jay] [Entered: 02/15/2018 09:03 PM] (71) |
| Jan 4, 2018 | 30 | **TEXT ONLY** ORDER granting motion to extend time to file appellee's principal brief [29] filed by Appellee Actavis Laboratories FL, Inc. Appellee's brief is due 02/15/2018. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [487262] [CAB] [Entered: 01/04/2018 09:54 AM] (0) |
| Jan 2, 2018 | 29 | MOTION of Appellee Actavis Laboratories FL, Inc. to extend the time to 02/15/2018 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 01/02/2018 by email. [486657] [William Jay] [Entered: 01/02/2018 02:27 PM] (8) |
| Jan 2, 2018 | 28 | Entry of appearance for Brian T. Burgess as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 01/02/2018 by email. [486653] [Brian Burgess] [Entered: 01/02/2018 02:21 PM] (2) |
| Dec 11, 2017 | 27 | 6 paper copies of the Opening Brief [26] received from Appellant Tris Pharma, Inc. [481716] [JCP] [Entered: 12/11/2017 04:16 PM] (0) |
| Dec 4, 2017 | 26 | BRIEF FILED for Appellant Tris Pharma, Inc. [25]. Number of Pages: 63. Service: 12/04/2017 by email. The paper copies of the brief should be received by the court on or before 12/14/2017. Appellee Actavis Laboratories FL, Inc.'s brief is due 01/16/2018. [480878] [CAB] [Entered: 12/07/2017 10:47 AM] (267) |
| Dec 4, 2017 | 25 | TENDERED from Appellant Tris Pharma, Inc.. Title: OPENING BRIEF. Service: 12/04/2017 by email. [480062] [Anna Brook] [Entered: 12/04/2017 04:21 PM] (267) |
| Nov 14, 2017 | 24 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [475328] [CAB] [Entered: 11/14/2017 01:12 PM] (0) |
| Nov 14, 2017 | 23 | **TEXT ONLY** ORDER granting motion to extend time to file appellant's principal brief [22] filed by Appellant Tris Pharma, Inc. Brief due 12/04/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [475327] [CAB] [Entered: 11/14/2017 01:11 PM] (0) |
| Nov 13, 2017 | 22 | MOTION of Appellant Tris Pharma, Inc. to extend the time to 12/04/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 11/13/2017 by email. [474992] [Anna Brook] [Entered: 11/13/2017 04:26 PM] (6) |
| Oct 19, 2017 | 21 | Notice of intent to file corresponding briefs on CD-ROM for Appellant Tris Pharma, Inc.. Service: 10/19/2017 by email. [469262] [Anna Brook] [Entered: 10/19/2017 05:34 PM] (3) |
| Oct 12, 2017 | 20 | Entry of appearance for Tiffany Mahmood as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 10/12/2017 by email. [467331] [Tiffany Mahmood] [Entered: 10/12/2017 12:20 PM] (2) |
| Oct 3, 2017 | 19 | Certificate of Interest for the Appellant Tris Pharma, Inc.. Service: 10/03/2017 by email. [465334] [Errol Taylor] [Entered: 10/03/2017 05:43 PM] (3) |
| Oct 3, 2017 | 18 | Docketing Statement for the Appellant Tris Pharma, Inc.. Service: 10/03/2017 by email. [465333] [Errol Taylor] [Entered: 10/03/2017 05:40 PM] (3) |
| Oct 3, 2017 | 17 | Entry of appearance for Jordan P. Markham as of counsel for Appellant Tris Pharma, Inc.. Service: 10/03/2017 by email. [465331] [Errol Taylor] [Entered: 10/03/2017 05:36 PM] (2) |
| Oct 3, 2017 | 16 | Entry of appearance for Anna Brook as of counsel for Appellant Tris Pharma, Inc.. Service: 10/03/2017 by email. [465330] [Errol Taylor] [Entered: 10/03/2017 05:33 PM] (2) |
| Oct 3, 2017 | 15 | Entry of appearance for Fredrick M. Zullow as of counsel for Appellant Tris Pharma, Inc.. Service: 10/03/2017 by email. [465329] [Errol Taylor] [Entered: 10/03/2017 05:31 PM] (2) |
| Oct 3, 2017 | 14 | Entry of appearance for Errol B. Taylor as principal counsel for Appellant Tris Pharma, Inc.. Service: 10/03/2017 by email. [465328] [Errol Taylor] [Entered: 10/03/2017 05:30 PM] (2) |
| Oct 3, 2017 | 13 | Entry of appearance for Michael B. Cottler as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465199] [Elizabeth Holland] [Entered: 10/03/2017 02:22 PM] (2) |
| Oct 3, 2017 | 12 | Certificate of Interest for the Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465194] [Elizabeth Holland] [Entered: 10/03/2017 02:17 PM] (4) |
| Oct 3, 2017 | 11 | Docketing Statement for the Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465190] [Elizabeth Holland] [Entered: 10/03/2017 02:15 PM] (3) |
| Oct 3, 2017 | 10 | Entry of appearance for Linnea P. Cipriano as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465186] [Linnea Cipriano] [Entered: 10/03/2017 02:11 PM] (2) |
| Oct 3, 2017 | 9 | Entry of appearance for Alexandra D. Valenti as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465181] [Alexandra Valenti] [Entered: 10/03/2017 02:08 PM] (2) |
| Oct 3, 2017 | 8 | Entry of appearance for David J. Zimmer as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465174] [David Zimmer] [Entered: 10/03/2017 02:04 PM] (2) |
| Oct 3, 2017 | 7 | Entry of appearance for Cynthia Lambert Hardman as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465173] [Cynthia Hardman] [Entered: 10/03/2017 01:59 PM] (2) |
| Oct 3, 2017 | 6 | Entry of appearance for William G. James as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465171] [William James] [Entered: 10/03/2017 01:55 PM] (2) |
| Oct 3, 2017 | 5 | Entry of appearance for William M. Jay as of counsel for Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465170] [William Jay] [Entered: 10/03/2017 01:52 PM] (2) |
| Oct 3, 2017 | 4 | Entry of appearance for Elizabeth J. Holland as principal counsel for Appellee Actavis Laboratories FL, Inc.. Service: 10/03/2017 by email. [465168] [Elizabeth Holland] [Entered: 10/03/2017 01:49 PM] (2) |
| Oct 2, 2017 | 3 | Amended Notice of Appeal for Tris Pharma, Inc. Service: 10/02/2017 by clerk. [464789] [CAB] [Entered: 10/02/2017 02:17 PM] (24) |
| Sep 19, 2017 | 2 | Note to file: The following cases are associated:17-2557 Lead with 17-2559 and 17-2560 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [462068] [17-2557, 17-2559, 17-2560] [CAB] [Entered: 09/19/2017 01:32 PM] (0) |
| Sep 19, 2017 | 1 | Appeal docketed. Received: 09/15/2017. [461949]Entry of Appearance due 10/03/2017. Certificate of Interest is due on 10/03/2017. Docketing Statement due 10/03/2017. Appellant's brief is due 11/20/2017. [CAB] [Entered: 09/19/2017 10:16 AM] (24) |
